NKG2D CAR-NK Cell Therapy in Patients With Refractory Metastatic Colorectal Cancer
NCT05213195
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
38
Enrollment
OTHER
Sponsor class
Conditions
Refractory Metastatic Colorectal Cancer
Interventions
DRUG:
NKG2D CAR-NK
Sponsor
Zhejiang University